4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-050065
Chief Medical Officer sold 5,000 shares at $34.92 ($174,604)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2021-08-04 | Option exercise | +5,000 | $5.18 | $25,875 | 114,277 | D: show line 1 in the form |
| Pang Phillip Chief Medical Officer | 2021-08-04 | Sale | −5,000 | $34.92 | $174,604 | 109,277 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $34.92 · $174,604 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2021-08-04 | Option exercise · Stock Option (Right to Buy) | −5,000 | 52,129 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…